Last $10.72 USD
Change Today -0.05 / -0.46%
Volume 1.2M
MACK On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael E. Porter Ph.D.

Strategy Advisor, Director, Chairman of Corporate Governance & Nominating Committee and Member of Executive Committee, Merrimack Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 57 board members in 8 different organizations across 9 different industries.

See Board Relationships
67$270,000

Background*

Prof. Michael E. Porter, Ph.D. has been Strategy Consultant of the Scotts Miracle-Gro Company since January 29, 2015. Prof. Porter serves as an Advisor at Hamilton Investment Partners, LLC. He has been a Strategy Advisor of Merrimack Pharmaceuticals, Inc. since 1999. Prof. Porter is the Bishop William Lawrence University Professor at Harvard Business School. He serves as an Advisor to business, government and the social sector. Prof. Porter also served as the Chief Executive ...

Read Full Background

Corporate Headquarters*

One Kendall Square
Cambridge, Massachusetts 02139

United States

Phone: 617-441-1000
Fax: 617-491-1386

Board Members Memberships*

Prior
Founder and Chairman of the Board
Former Director
1991-Present
Director
1993-Present
Director
1995-Present
Director and Member of Corporate Development Committee
1995-N/A
Former Director
1997-N/A
Director
1997-N/A
Former Director
2000-N/A
Former Director
2001-2012
Former Director, Member of Nominating & Corporate Governance Committee and Member of Strategy & Finance Committee
2006-N/A
Independent Director and Chairman of Strategy Committee
2010-Present
Strategy Advisor, Director, Chairman of Corporate Governance & Nominating Committee and Member of Executive Committee
2013-2015
Strategy Consultant

Education*

PhD 1973
Harvard University
MBA 1971
Harvard Business School
BSE 1969
Princeton University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$100,000
Total Calculated Compensation$270,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MACK:US $10.72 USD -0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brian A. Kenney Chairman, Chief Executive Officer and President
GATX Corp.
$924.1K
Kevin J. McNamara Chief Executive Officer, President and Director
Chemed Corp.
$857.9K
Gary W. Rollins Vice Chairman, Chief Executive Officer, Member of Executive Committee and Chairman of the Orkin Board of Directors
Rollins Inc.
$1.0M
William A. Furman Chairman, Chief Executive Officer and President
The Greenbrier Companies, Inc.
$829.3K
Robert J. Gillette Chief Executive Officer and Director
ServiceMaster Global Holdings, Inc.
$1.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERRIMACK PHARMACEUTICALS IN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.